Searched for
ENZENE BIOSCIENCES
Alkem Labs' Chakan facility gets six observations in USFDA inspection, no data integrity issuesAlkem Laboratories announced its subsidiary Enzene Biosciences received a Form 483 from the USFDA. The inspection at the Chakan manufacturi...- BITS Pilani sees all-campus median salary of Rs 28 lakh in first phase of 2025-26 placementsBITS Pilani students achieved over 920 placements in the first semester of the 2025-26 cycle. The all-campus median salary reached Rs 28 la...
- US tariffs on India a wrong approach: Phil Murphy, New Jersey GovernorNew Jersey has over 60 Indian life sciences companies including Biocon, BDR Pharma, Lupin, Meteoric Pharma, Dr Reddy's Labs, Rubicon Resear...
- Alkem's Enzene powers into US with $70 m investmentEnzene Biosciences, an Alkem Labs subsidiary, has inaugurated a new US manufacturing plant. The facility is located in New Jersey. This ven...
- Big chase for a cancer drug: The urgent need for affordable Keytruda alternativesKeytruda, a cancer treatment drug, has achieved $25 billion in global sales. Its mechanism boosts the immune system to fight cancer. In Ind...
- Alkem Labs to grow chronic therapies, biosimilars to drive future growth: MDAlkem Laboratories, a top-seller of antibiotics, is focusing on the chronic therapy segments and is investing heavily in biosimilars and co...
- Lupin Partners Enzene to roll out biosimilar Cetuximab hereIn July 2009, the US Food and Drug Administration (USFDA) approved Eli Lilly and Merck's cetuximab (Erbitux) for treatment of metastatic co...
- Lupin launches biosimilar cetuximab in pact with EnzeneCetuximab has received approval from the Drug Controller General of India (DCGI) for its effectiveness in treating head and neck cancer
- Alkem subsidiary Enzene launches adalimumab biosimilar in IndiaEnzene or its parent Alkem which is commercialising the drug didn't announce the price, but said it would be competitively priced.
- Eight Roads Ventures appoints Chintan Kothari as partner to focus on healthcare dealsThis year, the fund has backed companies including, Enzene Biosciences, a subsidiary of Alkem Laboratories, and Enko, a crop health firm.
- ETtech Deals Digest: tech slowdown continues, startup fundraising dropped 75% in January compared to last yearA majority of investments in January came for the late-stage startups, with $845 million being poured across 14 rounds.
- Enzene Biosciences raises $50 million to expand ops in India, US marketsIn a press statement, Enzene said it would leverage the fresh funds to enhance its manufacturing capabilities and drive expansion in its co...
- IT job vacancies slump 60% in January; Silicon Valley investor Tim Draper on Indian startupsThe IT and tech job market is under stress. As the year started with large scale layoffs globally, and in India, Information Technology ( I...
- Stocks in the news: NDTV, Tata Motors, Suven Pharma, Quess Corp, SiemensThe founders of NDTV, Radhika Roy and Prannoy Roy, will transfer 27.26% of their stake in the company to Adani Group-owned RRPR Holding. Co...
- Indian pharma industry may rebound to 8-11 pc growth rate; inflationary pressures, regulatory norms key risks: AlkemOn the outlook for the domestic business, Alkem Laboratories said, "With easing out of COVID-19 restrictions, resumption of travel, normali...
- 14 vaccine candidates from India look promising: Dr Renu Swarup, Department of BiotechnologyHuman trials for at least 3-4 candidates are likely to begin in the next 2-6 months. Biotechnology Industry Research Investment Council (BI...
- Government picks IIT, Bennett University proposals in war on CovidIn order to urgently develop “safe and effective biomedical solutions” against Covid-19, the department of biotechnology (DBT) under scienc...
- Biotech start-ups look for growth boostersAs risk capital flow for biotechnology start-ups in India picks up, entrepreneurs are now seeking greater support in policy, intellectual p...
Load More
